This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Sanofi, Euroapi, Pieris Pharmaceuticals Gmbh. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,547 
1 out of 1 
1 out of 37 
Years Active: 2019-2024
Title: The Innovations of Hans-Falk Rasser
Introduction
Hans-Falk Rasser is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of steroid hydroxylation, holding a total of five patents. His work has implications in various applications, particularly in biochemistry and pharmaceuticals.
Latest Patents
One of Hans-Falk Rasser's latest patents focuses on the 21-hydroxylation of steroids. This invention relates to a method for the 21-hydroxylation of steroids in cells. It also encompasses cells that express a steroid 21-hydroxylating enzyme or steroid 21-hydroxylase. Additionally, the patent includes expression vectors that comprise a nucleic acid encoding for a steroid 21-hydroxylase and a kit designed for carrying out the method for the 21-hydroxylation of steroids in cells.
Career Highlights
Throughout his career, Hans-Falk Rasser has worked with prominent companies in the pharmaceutical industry, including Sanofi and Euroapi. His experience in these organizations has allowed him to develop and refine his innovative approaches to steroid hydroxylation.
Collaborations
Hans-Falk Rasser has collaborated with notable colleagues such as Claus Lattemann and Thomas Stillger. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Hans-Falk Rasser's contributions to the field of steroid hydroxylation through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the pharmaceutical industry and the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile